Pulse Biosciences, Inc.PLSENASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank45
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P45
Within normal range
vs 3Y Ago
-3.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-49.27%
2024-9.97%
202330.06%
202213.06%
2021-52.30%
2020-2.91%
2019-43.94%
2018-77.24%
2017-68.06%
2016-138.48%